JOHN JORDAN: Open Payments
NPI 1548733249 · NORMAN, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,200 in 55 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $1,200
Food & beverage: $1,200
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $196 |
| PFIZER INC. | 9 | $164 |
| ABBVIE INC. | 6 | $162 |
| GlaxoSmithKline, LLC. | 10 | $149 |
| SHIELD THERAPEUTICS INC | 3 | $125 |
| Sumitomo Pharma America, Inc. | 5 | $119 |
| Lilly USA, LLC | 5 | $99 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Novo Nordisk Inc | 2 | $41 |
| Dexcom, Inc. | 1 | $38 |
Products named: AIRSUPRA, TRELEGY ELLIPTA, ACCRUFER, GEMTESA, QULIPTA, MOUNJARO, ELIQUIS, NURTEC ODT.
Industry payments across OK — which companies pay providers there.
